TNYA
Tenaya Therapeutics Inc
0.5657$
-6.3%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +24.8% | +62.1% | +116.5% | -0.3% | -2.5% | -0.4% | |
| – | – | – | – | – | – | – | |
| – | +34.3% | +74.9% | +73.8% | +3.7% | -11.5% | -20.9% | |
| – | +71.2% | +135.7% | +68.8% | +6.7% | -11.9% | -15.3% | |
| – | +31.5% | +99.9% | +72.5% | -2.5% | -12.3% | -21.0% | |
| – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | -1,404.5% | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.